1. Introduction {#sec1-1}
===============

The etiology of Obsessive-Compulsive Disorder (OCD) is still unclear. Existing neuro-imaging research shows that structural, functional and metabolic disturbance exists in the brain of OCD patients.^\[[@ref1]\]^ A currently accepted theory about etiological mechanism of OCD claims that the dysfunctions that exist on the Cortico- Striato-Thalamo-Cortical circuit (CSTC),^\[[@ref4]\]^especially on Orbitofrontal Cortex (OFC),^\[[@ref5]\]^ Anterior Cingulate Cortex (ACC),^\[[@ref6]\]^ striatum,^\[[@ref4]\]^ thalamus^\[[@ref7]\]^ and other parts of the circuit, are crucial for the pathogenesis of OCD. The OFC is considered a functional area for sensation, perception, motion, association and memory in human beings^\[[@ref8],[@ref9]\]^ ; and the ACC is a subcortical structure on the frontal lobe, which probably plays a role of regulation for advanced brain functions, such as management of emotional information, behavior planning, and execution of actions. ^\[[@ref10],[@ref11]\]^After measuring the neurometabolism on white matters of the frontal lobe in OCD teenage patients via MR scanner, Weber and colleagues ^\[[@ref12]\]^ reported that the decline of choline and N-Acetyl Aspartate (NAA) was found to be significant in these white matters, and the relationship between the decrease of substances and clinical symptoms of OCD was significant. Tukel and colleagues ^\[[@ref13]\]^ found that NAA/Cr decreased significantly in the ACC of OCD patients, and was negatively correlated with the clinical scores within OCD patients.

Magnetic Resonance Spectroscopy (MRS) is a technological approach, which measures cerebral metabolic substances via magnetic resonance. Among the MRS methods, proton magnetic resonance spectroscopy (1H-MRS) is the most widely used. Currently, there are relatively few studies on gamma-aminobutyric acid (GABA) in OCD. Previous studies have reported that plasma levels of GABA decreased in patients with OCD.^\[[@ref14]\]^ Simpson^\[[@ref15]\]^ found that GABA/W was significantly decreased in the dorsal anterior medial pre-frontal cortex (MPFC)in patients with OCD, and the decrease is negatively associated with age of onset.

Because there are so few studies on Gamma-aminobutyric acid in OCD patients and the question of whether or not a dysfunction exists remains inconclusive, our study focuses on the change of GABA concentration in the frontal lobe of patients with OCD in order to provide further objective data in the exploration of the etiology of OCD.

2. Objectives and Methods {#sec1-2}
=========================

2.1 Objectives {#sec2-1}
--------------

The obsessive-compulsive disorder group (OCD group) was made up of patients being treated for OCD at the outpatient department of the Shanghai Mental Health Center from June 2014 to March 2016. Inclusion criteria were the following: (1) meeting diagnostic criteria of OCD according to the *Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition* (DSM-IV); (2) patients were aged 18 to 54 years, were right-handed, both women and men were included, (3) score on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was higher than 3 points at the beginning of the study, (4) education level of middle school or higher. Exclusion criteria were the following: (1) having a severe primary physical disease or metal implant, (2) having another diagnosis from axis I of DSM-IV (assessment via MINI). Patients enrolled were diagnosed and evaluated by two senior psychiatrists and provided written informed consent to participate in this study.

The healthy control group (HC group) was made up of volunteers recruited via public advertisement. Inclusion criteria were the following: (1) being assessed by researchers strained in the use of the Mini-international Neuropsychiatric Interview (MINI) (Chinese version) and having DSM-IV mental disorders excluded, (2) being aged 18 to 54 years, being right-handed, both women and men were included, (3) education level of middle school or higher, (4) no personal or family history of mental disorders. Those with severe primary physical diseases or metal implants were excluded.

88 unmedicated patients were enrolled into the OCD group (10 individuals declined to participate in the study and were dropped at the beginning). In the OCD group 46 patients were given magnetic resonance scanning of the OFC: 24 males and 22 females, mean (sd) age 29.1 (6.5) years and mean (sd) years of education 14.9 (1.8); 32 patients were given scanning of the ACC area: 17 males and 15 females, mean (sd) age 28.6 (5.4) years, mean (sd) years of education 14.7 (2.4).

76 individuals were enrolled in the HC group, including 44 including who accepted scanning for the OFC area: 23 males and 21 females, mean (sd) age 28.7 (6.5) years, mean (sd) years of education15.1 (1.7); 32 patients accepted scanning for the brain area of ACC: 18 males and 14 females, mean (sd) age 27.5 (5.4) years, mean (sd) years of education 14.8 (2.2).

There were no statistically significant differences found in gender, age and or level of education between the OCD group and control group or between the participants who were scanned in the OFC and ACC.

This study was approved by the IRB of the Shanghai Mental Health Center. All individuals provided written informed consent to participate in this study.

2.2 Methods {#sec2-2}
-----------

### 2.2.1 Questionnaires and Scales {#sec3-1}

The following questionnaires were used to gather patient data: (1) General information questionnaire: a self-created questionnaire including general items such as name, gender, age, years of education, age of onset for illness, circumstances surrounding disease onset, history of illness and others; (2) Yale-Brown Obsessive Compulsive Scales (Y-BOCS), which was designed by Goodman and colleagues.^\[[@ref16]\]^On this questionnaire, which is widely used in clinical practice, one of the scales specifically assesses the severity of OCD symptoms. The reliability and validity of Y-BOCS Chinese edition has been demonstrated in a previous study by Xu and colleagues,^\[[@ref17]\]^ which showed that the internal consistency coefficient of the scale was 0.75. The Y-BOCS is a10-item scale, each item rated from 0 to 4. The obsessive symptoms are evaluated by items 1 to 5, and the compulsive symptoms are assessed by items 6 to 10. (3) The Hamilton Depression Scale (HAMD) was designed by Hamilton in 1960 ^\[[@ref18]\]^, and is the most widely used scale for assessing the state of depression in clinical practice. The HAMD includes 17 items, each item is also rated from 0 to 4. A score of 0 to 6 is considered to be within normal limits, scores of 7 to 17 indicate that possible depression exists, scores of 18 to 24 indicate that depression is definitely present, and a score greater than 24 indicates presence of severe depression. (4)The Hamilton Anxiety Scale (HAMA) was designed by Hamilton in 1959^\[[@ref7]\]^, and includes 14 items, with each item also rated from 0 to 4. According to the information provided by the China cooperative group for the HAMA, a score higher than 29 indicates extremely severe anxiety, scores of 21 to 29 indicates presence of severe anxiety, score of 14 to 28 presence of some anxiety, scores of 7 to 27 indicate presence of possible anxiety, and a score less than 7 indicates no anxiety present.

### 2.2.2 Magnetic Resonance {#sec3-2}

Siemens Verio 3.0T magnetic resonance scanner with 32 channel array coil was used to perform the scanning in following steps: Firstly, a routine brain scan was performed on participants in order to make a T1-weighted image of entire 3D structure of the brain by Mega-Press sequence. Secondly, OFC area of patients was set as the volumes of interest (VOI, [pic.A](#fig002){ref-type="fig"}), setting voxel size at 30mm right-to-left, 30mm top-to-bottom, and 30mm prior-to-post, TR=1500ms, TE=68ms, scan time: 6m30s. Thirdly, the ACC was set as the VOI, where the anterior grim is bounded in the genu of corpus callosum, between the sulcus of corpus callosum and cingulate sulcus ([pic.B](#fig002){ref-type="fig"}); the brain was scanned with the following conditions: voxel size 20mm right-to-left, 20mm top-to-bottom, and 40mm prior-to-post, TR=1500ms, TE=68ms, scan time: 8m30s. The VOIs were set consistently by a trained researcher, who was blinded to the assessment of scales and diagnosis of participants. The processing of fluid attenuated inversion recovery (FLAIR) was used in the chemical shift selective saturation (CHESS) sequence, and was acquired individually using equipment hand-coded mean field protocol.

2.3 Analysis of magnetic resonance imaging data {#sec2-3}
-----------------------------------------------

This study focused on the spectral peak at 3.0 ppm. According to the characteristics of GABA which has a low signal to noise ratio and overlapping spectral peak, software LC model 6.3 was used to analyze the absolute concentration and relative error of metabolic products of GABA, and data in which the estimation error was less than 20% was chosen for further statistical analysis.

2.4 Statistical Analysis {#sec2-4}
------------------------

Statistical analysis was processed by SPSS software version 19.0. Participants' age, years of education, Y-BOCS scores, HAMA scores and HAMD scores were analyzed using paired t-tests; gender was analyzed using chi-square tests; Pearson correlation analysis was used to analyze the relevance between abnormal substance concentration and clinical symptoms of OCD (as assessed by Y-BOCS, HAMD and HAMA). Statistical significance level was set at *p*\<0.05.

3. Results {#sec1-3}
==========

3.1 Analysis of substance concentration between groups {#sec2-5}
------------------------------------------------------

Compared with the control group, this study found that GABA/W and NAA/W were significantly decreased in the OFC of OCD patients (*p*=0.031, *t*=-2.193), no abnormal changes were found in Glx/W, and the GABA/W in ACC had a decreasing trend (see [tables 1](#table001){ref-type="table"}, [2](#table002){ref-type="table"}).

3.2 Correlational analysis between concentration of substances and clinical features {#sec2-6}
------------------------------------------------------------------------------------

There was a significant negative correlation found between the concentration of GABA/W and scores on Y-BOCS (Y-BOCS-O, *p*=0.037, *r*=-0.221; Y-BOCS-C, *p*=0.007, *r*=-0.283; and Y-BOCS-T *p*=0.014, *r*=-0.259). The concentration of NAA/W was negatively correlated with the scores on Y-BOCS-O (p\<0.001, *r*=-0.33), Y-BOCS-C (p\<0.001, *r*=-0.38) and Y-BOCS-T (p\<0.001. *r*=-0.36), as well as with the age of onset (*p*=0.01, *r*=-0.26), HAMD (p\<0.001, *r*=-0.32) and HAMA scores *(p*\<0.001, *r*=-0.35). ([Table 3](#table003){ref-type="table"})

4. Discussion {#sec1-4}
=============

4.1 Main findings {#sec2-7}
-----------------

As we know, this study is the first to find that the concentration of GABA/W in the OFC in patients with OCD has a significant decrease. As well, our study also found that the Glx/W level was normal, and the GABA/W in the ACC area tended to decrease. These results indicate that dysfunction of GABAergic system is related with psychopathology in OCD, which is consistent with findings by Simpson and colleagues^\[[@ref15]\]^, which suggested that the concentration of GABA/W was decreased in the MPFC, but the change of the glutamate concentration level was not significant. GABA is mainly generated by glutamate via glutamic acid decarboxylase. Previous studies reported that glutamate is significantly increased in the cerebral spinal fluid of OCD patients.^\[[@ref19]\]^ Another study reported a change in glutamate concentration and abnormality in genes polymorphism, including the gene of glutamate-relative N- methyl-D-aspartic acid receptor *(NMDA), NR2B, Grik2*, and SLA1C1.Meanwhile the glutamate regulator riluzole was found to have a function of decreasing Y-BOCS scores for patients with OCD when applied as a synergistic agent.^\[[@ref20]\]^ As an excitatory neurotransmitter^\[[@ref21]\]^, the disturbance of glutamate also results in the abnormality of inhibitory neurotransmitter. The main symptom of OCD is the intrusive thoughts, which the individual is unable to control. The neurophysiological mechanism of the symptom as previously investigated includes disturbance of GABA and dysregulation of the NMDA receptor. Also, in previous studies, when researchers measured cortical inhibitory and facilitatory neurotransmitters via inhibition of short time interval (SICI), cortical cortex quiescent (CSP) and cortical facilitation (ICF), they found that patients with OCD have shorter CSP, increasing ICF and no significant SICI when compared with healthy controls. All these results suggest that injuries exist on signal pathways mediated by GABA-β receptor and NMDA receptor in patients with OCD, which is probably related to the etiological mechanism of OCD symptoms.^\[[@ref22]\]^

The OFC is a classical brain area of CSTC. Previous studies reported that the CSTC has metabolic disturbance in OCD patients.^\[[@ref23]\]^ Our results, suggesting that metabolic dysfunctions exist in the OFC, are consistent with previous studies on GABA in OCD patients. Therefore, the results suggest that OFC is relative to psychopathology in OCD, lending crucial evidence supporting the conclusion of dysfunction in CSTC. Researchers have also reported that GABA decreases in the MPFC, which is related to clinical symptoms in OCD.^\[[@ref15]\]^Zurowski and colleagues^\[[@ref23]\]^ attempt to predict the efficacy of cognitive-behavior treatment (CBT) in OCD treatment via exploration of neuro-metabolism in the OFC, the results suggested that the effect of CBT is significantly correlated with the (myo-) inositol (MI) in the OFC area, but the MI levels at baseline did not significantly differ between OCD and control groups. Another research compared the metabolism of head of caudate (HOC) nucleus and white matter of the OFC in OCD patients relative to healthy controls, and found that Glx/Cr and NAA/Cr levels were significantly increased in the OFC white matter of their right hemisphere and the MI/Cr level was decreased on caudate head of both sides.^\[[@ref24]\]^Why are these results inconsistent to our findings? The reasons likely include the difference of equipment (study used 1.5T MRI), sample size, voxels and parameters. Whiteside and colleagues ^\[[@ref25]\]^ compared patients with OCD and healthy controls, and found that NAA and Cr were significantly decreased in the Orbito Frontal White Matter (OFWM), and there was no significant difference of NAA and Glx in the caudate head at baseline. Moreover in their research, after behavior therapy, the NAA in the left HOC significantly increased. Another study by this group ^\[[@ref26]\]^ found a significantly decreased NAA in the HOC in teenage OCD patients; these findings are consistent our results. NAA is thought to be related with the integrity and activity of neurons, therefore the dysfunction of NAA indicates abnormality of neuron integrity in the brain of individuals with OCD. This has a great potential to be regarded as a specific endophenotype for OCD.

ACC is also a typical brain area of the CSTC circuit. Previous studies reported that dysfunction of metabolism also exists in the ACC. ^\[[@ref27]\]^Tukel and colleagues^\[[@ref13]\]^ also found significant NAA/Cr loss in the ACC, and a trend of decreasing in the caudate nucleus and putamen. Also, after 12 weeks treatment of sertraline, the NAA/Cr of OCD group did not significantly differ from controls. Ortiz and colleagues ^\[[@ref27]\]^ compared individuals with OCD and controls, and reported no significant difference in the glutamate complex, a result that is also consistent with our findings. Although all of these findings suggest that metabolic dysfunction exists in the ACC, there are still inconsistencies amongst results, which may require further studies with larger sample sizes to provide definitive evidence.

4.2 Limitations {#sec2-8}
---------------

There are several limitations in our study. First, the sample size is not sufficient to achieve acceptable reliability to reach a strong conclusion. Second, the characteristics of GABA, which have low signal to noise ratio and overlapping spectral peak, made the concentration itself difficult to measure precisely, a more rigorous method of analysis is required. Finally, OCD is a disease with heterogeneous features that may influence the results due to difference of subtypes. Therefore, more precise results require distinctly calculating for each OCD subtype, for which homogeneous OCD cases should been chosen as far as possible. In further research, we will expand the sample size and enroll OCD patients with only one prominent symptom (i.e. compulsions or obsessions) and analyze data according to subtype grouping.

4.3 Implication {#sec2-9}
---------------

Our research once again shows that metabolic dysfunctions exists on the CSTC circuit, and for the first time explored the GABA abnormality in the OFC within OCD patients, which is negatively correlated with clinical symptoms. These results indicate that GABA in OCD is related to the psychopathology of OCD, and further illuminate the etiology of OCD.
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###### 

Comparison of Substances Concentration in Orbitofrontal Cortex between OCD group and HC group

  Substance                             OCD group        HC group         *t*      *p*
  ------------------------------------- ---------------- ---------------- -------- -----------------------------------
  GABA/W^[a](#t1fn02){ref-type="fn"}^   0.0246(0.0075)   0.0280(0.0072)   -2.193   0.031[\*](#t1fn01){ref-type="fn"}
  NAA/W^[b](#t1fn03){ref-type="fn"}^    0.0083(0.0024)   0.0097(0.0017)   -3.223   0.002[\*](#t1fn01){ref-type="fn"}
  Glx/W^[c](#t1fn04){ref-type="fn"}^    0.0147(0.0029)   0.0154(0.0031)   -1.160   0.249

\*p\<0.05 is statistically significant.

^a^GABA/W, concentration of gamma-aminobutyric acid

^b^NAA/W, concentration of N-acetyl-aspartate

^c^Glx/W, concentration of glutamate/glutamine complex

###### 

Comparison of Substances Concentration in Anterior Cingulate Cortex between OCD group and HC group

  Substance                             OCD group        HC group         *t*      *p*
  ------------------------------------- ---------------- ---------------- -------- -------
  GABA/W^[a](#t2fn01){ref-type="fn"}^   0.0277(0.0062)   0.0312(0.0083)   -1.921   0.059
  NAA/W^[b](#t2fn02){ref-type="fn"}^    0.0120(0.0036)   0.0131(0.0036)   -1.151   0.255
  Glx/W^[c](#t2fn03){ref-type="fn"}^    0.0158(0.0027)   0.0163(0.0027)   -0.680   0.499

^\*^p\<0.05 is statistically significant.

^a^GABA/W, concentration of gamma-aminobutyric acid

^b^NAA/W, concentration of N-acetyl-aspartate

^c^Glx/W, concentration of glutamate/glutamine complex

###### 

Comparative analysis between substances concentration and clinical data of participants with OCD.

  Substances   Age      Education years   Onset years                          Entire OCD course   YBOCS^[c](#t3fn03){ref-type="fn"}^-O   YBOCS-C                                YBOCS-T                                HAMA^[d](#t3fn04){ref-type="fn"}^      HAMD^[e](#t3fn05){ref-type="fn"}^
  ------------ -------- ----------------- ------------------------------------ ------------------- -------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- --------------------------------------
  GABA         -0.12    -0.09             -0.20                                -0.14               -0.22                                  -0.28                                  -0.38                                  -0.18                                  -0.18
  /W r(p)      (0.24)   (0.36)            (0.05)                               (0.18)              (0.03)[\*](#t3fn01){ref-type="fn"}     (0.01)[\*](#t3fn01){ref-type="fn"}     (0.00)[\*\*](#t3fn02){ref-type="fn"}   (0.09)                                 (0.08)
  NAA          -0.03    -0.14             -0.26                                -0.19               -0.33                                  -0.38                                  -0.36                                  -0.32                                  -0.35
  /Wr(p)       (0.78)   (0.17)            (0.01)[\*](#t3fn01){ref-type="fn"}   (0.07)              (0.00)[\*\*](#t3fn02){ref-type="fn"}   (0.00)[\*\*](#t3fn02){ref-type="fn"}   (0.00)[\*\*](#t3fn02){ref-type="fn"}   (0.00)[\*\*](#t3fn02){ref-type="fn"}   (0.00)[\*\*](#t3fn02){ref-type="fn"}

\*p\<0.05

\*\*p\<0.001 are statistically significant.

^a^GABA/W, concentration of gamma-aminobutyric acid

^b^NAA/W, concentration of N-acetyl-aspartate

^c^Yale-Brown Obsessive Compulsive Scale

^d^ Hamilton Anxiety scale

^e^ Hamilton Depression scale
